SARAH SMITH: Open Payments
NPI 1700404951 · DALLAS, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$310 in 13 payments from 10 companies in 2025. Trend: 2023 $616 · 2024 $342 · 2025 $310
Food & beverage: $310
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 2 | $55 |
| Daiichi Sankyo Inc. | 2 | $52 |
| ABBVIE INC. | 2 | $40 |
| Novartis Pharmaceuticals Corporation | 1 | $35 |
| E.R. Squibb & Sons, L.L.C. | 1 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $25 |
| Merck Sharp & Dohme LLC | 1 | $22 |
| Immunocore Limited | 1 | $21 |
| Incyte Corporation | 1 | $16 |
| Regeneron Healthcare Solutions, Inc. | 1 | $15 |
Products named: IMFINZI, CREON, PLUVICTO, OPDIVO, Enhertu, Xofigo, DATROWAY, KEYTRUDA.
Industry payments across TX — which companies pay providers there.
